Beckwith-Wiedemann Syndrome: Comprehensive Imaging Guide and Clinical Overview
Overview
Beckwith-Wiedemann Syndrome (BWS) is a rare genetic overgrowth disorder characterized by diverse clinical features that vary widely in severity and presentation. It mainly involves abnormal growth regulation due to genetic or epigenetic alterations on chromosome 11p15.5. Key clinical manifestations include macroglossia (enlarged tongue), abdominal wall defects such as omphalocele or umbilical hernia, lateralized or asymmetric overgrowth, organomegaly, neonatal hypoglycemia, distinctive ear anomalies, and increased risk of embryonal tumors like Wilms tumor and hepatoblastoma. The syndrome affects approximately 1 in 10,000 to 11,000 live births and shows both sporadic and familial inheritance patterns.
Why is it called so?
The syndrome is named after physicians John Beckwith and Hans-Rudolf Wiedemann, who first described the disorder independently in the 1960s. The naming honors their identification of the pattern of clinical findings now recognized as BWS. Clinically, the syndrome is defined by overgrowth features including macrosomia, macroglossia, and congenital abdominal wall defects. Inheritance is complex: about 80% of cases arise sporadically from epigenetic changes affecting imprinted growth-regulating genes on chromosome 11p15.5, with 5-10% showing familial transmission through autosomal dominant inheritance involving imprinting defects or mutations in genes such as CDKN1C.
Key Imaging Features
1. Macroglossia is readily visualized on ultrasound and MRI as an enlarged tongue, sometimes causing airway and feeding difficulties.
2. Abdominal wall defects including omphalocele (herniation of abdominal contents into the umbilical cord) and umbilical hernia are identified on prenatal and postnatal ultrasound and CT scans.
3. Asymmetric or lateralized overgrowth can be seen in musculoskeletal imaging, showing differential limb size or unilateral organ enlargement.
4. Organomegaly affects abdominal organs such as the liver, kidneys, and pancreas, visible on ultrasound, CT, and MRI with corresponding volumetric enlargement.
5. Increased risk and early detection of embryonal tumors, including Wilms tumor and hepatoblastoma, are critical imaging considerations: ultrasound and MRI/CT are used for tumor surveillance and characterization.
Imaging Modality Specifics
Ultrasound is the primary modality for initial assessment, particularly prenatal and neonatal scans for abdominal wall defects, organomegaly, and tumor surveillance. It is non-invasive, readily available, and dynamic for vascular flow evaluation.
CT scans provide high-resolution imaging of abdominal structures, essential to evaluate the extent of organ involvement, abdominal wall anatomy, and detect tumors by their density and enhancement patterns. CT is often used when ultrasound findings are inconclusive or for detailed preoperative planning.
MRI offers superior soft tissue contrast, beneficial for evaluating macroglossia, musculoskeletal asymmetry, and liver or kidney tumors. MRI sequences such as T1-, T2-weighted images, and diffusion-weighted imaging help characterize tissue composition and vascularity without ionizing radiation exposure, useful in repeated follow-ups.
X-rays are less commonly specific but can assist in detecting skeletal asymmetry, calcifications, or lung assessment if thoracic involvement is suspected.
Pathophysiology
Beckwith-Wiedemann Syndrome results from dysregulation of imprinted genes within the chromosome 11p15.5 region, which controls fetal and postnatal growth. Epigenetic alterations lead to abnormal gene expression—such as overexpression of IGF2, a growth-stimulating factor, and loss of CDKN1C function, a growth suppressor—which cause cellular overproliferation. These molecular perturbations manifest as the overgrowth of organ systems and soft tissues observed on imaging. The abdominal wall defects arise from improper closure of embryonic structures, and the tumor predisposition relates to disrupted growth regulatory pathways promoting embryonal tumorigenesis.
Differential Diagnosis
Disorders with imaging similarities to BWS include:
Sotos syndrome: Also an overgrowth syndrome but lacks abdominal wall defects and has distinct craniofacial features visible on MRI and CT.
Simpson-Golabi-Behmel syndrome: Features overgrowth and macroglossia but is X-linked recessive with additional skeletal anomalies distinguishable on X-ray.
Isolated hemihyperplasia: Presents with asymmetric overgrowth but without the spectrum of visceral organ enlargements or abdominal wall anomalies typical of BWS.
Other genetic imprinting disorders may show some overlapping features but differ by clinical presentation and molecular diagnostics; imaging signs must be correlated with genetic tests.
Clinical Correlation
The imaging findings in Beckwith-Wiedemann Syndrome closely correlate with clinical symptoms. Macroglossia observed on MRI explains feeding difficulties and airway obstruction risks. Abdominal wall defects seen on ultrasound or CT correspond to physical protrusions reducing abdominal muscle integrity. Lateralized overgrowth contributes to limb length or volume discrepancies, affecting mobility and function. Organomegaly detected on imaging aligns with palpable abdominal masses and informs tumor surveillance strategies vital to early cancer detection. Neonatal hypoglycemia relates mechanistically to pancreatic islet cell hyperplasia seen on imaging and pathology.
Imaging Protocols and Techniques
For prenatal evaluation, detailed ultrasound with fetal MRI is recommended to identify abdominal wall defects, macroglossia, and large kidneys or liver. Neonatal and infant imaging protocols prioritize ultrasound screening biannually or quarterly for early tumor detection.
When ultrasound is inconclusive, contrast-enhanced CT is employed for tumor delineation and abdominal organ assessment, using low-dose protocols to minimize radiation exposure.
MRI protocols include T1 and T2 sequences for anatomical detail, diffusion-weighted imaging to identify malignant transformation, and MR angiography to assess vascular anomalies. Imaging pitfalls include potential difficulty differentiating organ enlargement from neoplastic lesions; thus, serial imaging and correlation with biomarker testing are critical.
Regular imaging follow-up is mandatory due to the progressive nature of overgrowth and tumor risks, with individualized protocols based on molecular subtype and clinical presentation.
Improve Content And Help Your Colleagues!
Found an error in the post? Please let us know using our contact page and we will update it with due credits!
If you wish to contribute radiological images for this case (or any other article on the website), you can submit them here and you will be duly credited: Submit radiology case